Skip to main content

Want a detailed portfolio tracker?

Orchestra BioMed (OBIO) P/E (2021 - 2026)

Orchestra BioMed (OBIO) P/E from Mar 31, 2021 to Jul 21, 2026. The TTM Orchestra BioMed (OBIO) P/E is -3.31. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Orchestra BioMed (OBIO)

YearP/EChange
2026-3.31-0.18%
2025-3.32+37.12%
2024-2.42-59.22%
2023-5.94+220.26%
2022-1.85-98.94%
2021-174.37N/A

Comparison Orchestra BioMed (OBIO) P/E with competitors

Orchestra BioMed (OBIO) P/E is -3.31.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.13%
ENLVEnlivex Ltd0.07-102.26%
FGENFibroGen Inc0.24-107.24%
CHRSCoherus Biosciences Inc0.85-125.60%
FBIOFortress Biotech Inc0.95-128.63%
ORMPOramed Pharmaceuticals Inc1.50-145.34%
AGENAgenus Inc3.01-190.79%
INVAInnoviva Inc3.15-195.15%
VXRTVaxart Inc3.55-207.08%
CRMDCorMedix Inc3.63-209.46%
CVACCureVac N.V.4.45-234.11%
GLPGGalapagos NV4.86-246.58%
SRPTSarepta Therapeutics Inc4.88-247.28%
ABEOAbeona Therapeutics Inc5.39-262.52%
ABUSArbutus Biopharma Corp5.60-268.80%
ZVRAZevra Therapeutics Inc5.89-277.60%
SPROSpero Therapeutics Inc6.23-287.89%
CGENCompugen Ltd6.31-290.47%
RIGLRigel Pharmaceuticals6.87-307.31%
SLXNSilexion Therapeutics Corp7.30-320.10%
OMEROmeros Corporation9.26-379.31%
AUPHAurinia Pharmaceuticals Inc9.58-389.15%
PLXProtalix BioTherapeutics Inc10.89-428.55%
ACADAcadia Pharmaceuticals Inc11.73-453.81%
TBPHTheravance Biopharma Inc12.26-469.91%
ADMAAdma Biologics Inc12.42-474.62%
HRMYHarmony Biosciences Holdings Inc13.82-516.91%
SABSSAB Biotherapeutics Inc14.14-526.44%
NAGENiagen Bioscience Inc14.82-547.01%
INCYIncyte Corp15.82-577.32%
REGNRegeneron Pharmaceuticals Inc15.86-578.34%
PBYIPuma Biotechnology Inc17.32-622.36%
CPRXCatalyst Pharmaceuticals Inc17.44-626.09%
EXELExelixis Inc17.54-629.07%
TGTXTG Therapeutics Inc18.97-672.14%
MDXGMimedx Group Inc20.55-720.00%
XOMAXOMA Royalty Corp22.87-790.07%
ARGXArgen X SE24.30-833.01%
CTMXCytomX Therapeutics Inc24.82-848.79%
XOMAOXOMA Royalty Corp25.34-864.59%
HALOHalozyme Therapeutics Inc25.62-873.01%
XOMAPXOMA Royalty Corp25.67-874.41%
VRTXVertex Pharmaceuticals Inc27.99-944.53%
RPRXRoyalty Pharma plc - Class A28.69-965.43%
SLNOSoleno Therapeutics Inc29.02-975.32%
ASNDAscendis Pharma A/S30.09-1007.61%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1243.71%
APLSApellis Pharmaceuticals Inc39.02-1277.18%
BMRNBiomarin Pharmaceutical Inc42.21-1373.43%
KRYSKrystal Biotech Inc45.34-1467.90%
ONCBeiGene Ltd69.54-2197.87%
PHARPharming Group N.V.75.03-2363.34%
TECHBio-Techne Corp101.96-3175.84%
VCELVericel Corp109.92-3416.06%
ALNYAlnylam Pharmaceuticals Inc117.96-3658.72%
GMABGenmab140.29-4332.24%
TLXTelix Pharmaceuticals Ltd162.15-4991.76%
CORTCorcept Therapeutics Inc212.86-6521.40%